CLS CLS AI
$385.39
+234.02% 1Y
Market & Price
Market Cap
-
Current Price
$385.39
High / Low (52W)
$422.21 / $115.38
Beta
-
Valuation
Stock P/E
-
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
-
Profitability & Returns
ROCE
31.64%
ROE
-
ROA
-
Profit Margin
-
Op Margin
-
EPS (Latest Qtr)
$1.83
EPS (TTM)
$-
Balance Sheet & Liquidity
Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
$7.21B
Current Assets
$5.67B
Working Capital
$1.73B
Ownership
Promoter Holding
-
Chg in Prom Hold
-
FII / Inst Holding
-
Chg in FII Hold
-
Financial Snapshot
Enterprise Value
-
Total Revenue (TTM)
-
EBITDA
-
Free Cash Flow
-
Operating Cash Flow
-
Shares Outstanding
-
Gross Margin
-
Payout Ratio
-
Growth (CAGR)
Revenue 5Y
19.56%
Profit 5Y
66.58%
Revenue (YoY)
-
Earnings (YoY)
-
PROS
- Healthy ROCE of 31.6%.
- Compounding revenue at 19.6% over 5 years.
- Profit CAGR of 66.6% over 5 years.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Ad space
Quarterly Results
Figures in USD.
| Metric | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.21B | 2.39B | - | 2.65B | 2.89B | 3.19B | 3.65B | 4.05B |
| Cost of Revenue | - | - | - | 2.37B | 2.52B | 2.78B | 3.22B | 3.61B |
| Gross Profit | 222.10M | 253.80M | - | 273.90M | 371.00M | 416.10M | 433.10M | 437.20M |
| Operating Expenses | - | - | - | 141.20M | 84.00M | 86.20M | 112.30M | 169.50M |
| Operating Income | 125.80M | 132.90M | - | 132.70M | 287.00M | 329.90M | 320.80M | 267.70M |
| EBITDA | - | - | - | 164.80M | 316.10M | 364.00M | 366.60M | 311.90M |
| Interest Expense | - | - | - | 13.70M | 13.50M | 12.80M | 12.60M | 16.00M |
| Pretax Income | - | - | - | 113.70M | 257.30M | 310.90M | 301.30M | 256.30M |
| Tax Provision | - | - | - | 27.50M | 46.30M | 43.10M | 33.80M | 44.00M |
| Net Income | 91.80M | 95.00M | - | 86.20M | 211.00M | 267.80M | 267.50M | 212.30M |
| Diluted EPS | 0.77 | 0.80 | - | 0.74 | 1.82 | 2.31 | 2.31 | 1.83 |
| R&D Expense | 16.50M | 19.40M | 18.70M | 17.60M | 34.00M | 36.40M | - | 41.20M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 7.25B | 7.96B | 9.65B | 12.39B |
| Cost of Revenue | - | 6.60B | 7.21B | 8.61B | 10.90B |
| Gross Profit | - | 649.70M | 754.10M | 1.03B | 1.49B |
| Operating Expenses | - | 353.70M | 403.70M | 415.00M | 423.70M |
| Operating Income | - | 296.00M | 350.40M | 618.70M | 1.07B |
| EBITDA | - | 406.70M | 515.70M | 736.20M | 1.21B |
| Interest Expense | - | 51.70M | 78.90M | 52.10M | 52.60M |
| Pretax Income | - | 239.10M | 306.00M | 532.20M | 983.20M |
| Tax Provision | - | 59.00M | 61.60M | 104.20M | 150.70M |
| Net Income | - | 180.10M | 244.40M | 428.00M | 832.50M |
| Diluted EPS | - | 1.18 | 2.03 | 3.61 | 7.16 |
| R&D Expense | - | 46.30M | 60.90M | 78.00M | 118.20M |
Compounded Sales Growth
| 5 Years: | 19.56% |
| 1 Year: | - |
Compounded Profit Growth
| 5 Years: | 66.58% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | +234.02% |
| 6 Months: | +17.59% |
| 3 Months: | +38.81% |
| 1 Month: | +2.35% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 5.63B | 5.89B | 5.99B | 7.21B |
| Current Assets | - | 4.33B | 4.51B | 4.51B | 5.67B |
| Cash & Equivalents | - | 374.50M | 370.40M | 423.30M | 595.60M |
| Inventory | - | 2.35B | 2.10B | 1.76B | 2.19B |
| Receivables | - | 1.39B | 1.80B | 2.07B | 2.64B |
| Total Liabilities | - | 3.95B | 4.12B | 4.09B | 5.00B |
| Current Liabilities | - | 3.06B | 3.22B | 3.02B | 3.94B |
| Long Term Debt | - | 606.60M | 648.30M | 770.20M | 750.50M |
| Total Debt | - | 786.10M | 675.30M | 796.70M | 776.50M |
| Total Equity | - | 1.68B | 1.77B | 1.90B | 2.22B |
| Shares Outstanding | - | 121.64M | 118.95M | 116.10M | 116.71M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 211.10M | 326.20M | 473.90M | 659.50M |
| Investing Cash Flow | - | -108.90M | -122.40M | -212.50M | -203.70M |
| Financing Cash Flow | - | -121.70M | -207.90M | -208.50M | -283.50M |
| Capital Expenditure | - | -109.00M | -125.10M | -170.90M | -201.20M |
| Free Cash Flow | - | 102.10M | 201.10M | 303.00M | 458.30M |
| Net Change in Cash | - | -19.50M | -4.10M | 52.90M | 172.30M |
| Share Buybacks | - | 34.60M | 35.60M | 152.00M | 153.40M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 9.0% | 9.5% | 10.7% | 12.1% |
| Operating Margin % | - | 4.1% | 4.4% | 6.4% | 8.6% |
| Net Margin % | - | 2.5% | 3.1% | 4.4% | 6.7% |
| ROE % | - | 10.7% | 13.8% | 22.6% | 37.6% |
| ROCE % | - | 11.5% | 13.1% | 20.9% | 32.7% |
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CLS
No recent headlines available.